Salinomycin

Star0

DB11544ExperimentalVet approvedSmall molecule

Salinomycin: Overview.

Mechanism: Pharmacologically active on Signal transducer and activator of transcription 3 and Low-density lipoprotein receptor-related protein 6
Curator reviewed
Formula / weight: C₄₂H₇₀O₁₁ · 751.011 g/mol (avg)
Also known as: Procoxacin

Resolves to

Compound

UNII62UXS86T64CAS53003-10-4ChEMBLCHEMBL1208572ChEBI80025KEGGD08502

Clinical / RWD

RxNorm1311566

Structure

InChIKeyKQXDHUJYNAXLNZ-XQSDOZFQSA-NSMILES

[H][C@@](C)(C(=O)[C@]([H])(CC)[C@@]1([H])O[C@@]2(O[C@@]3(CC[C@](C)(O3)[C@@]3([H])CC[C@](O)(CC)[C@]([H])(C)O3)[C@]([H])(O)C=C2)[C@]([H])(C)C[C@]1([H])C)[C@@]([H])(O)[C@]([H])(C)[C@]1([H])O[C@]([H])(CC[C@]1([H])C)[C@@]([H])(CC)C(O)=O

Targets

P40763STAT3O75581LRP6

Transporters

P08183ABCB1

What you can answer from here — as of August 30, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

56Drug interactionsStructured to mechanism, not free text

15+ReferencesStructured and connected to the statements they support

Which drugs share a target with Salinomycin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account